European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live10-27 23:13

European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, falling 0.31% to 1,891.64 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications companies Ericsson (ERIC) and Nokia (NOK), which rose 1.4% and 1.3% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (FOCL), which were up 1.1% and 0.8% respectively.

The decliners from continental Europe were led by oil and gas company Eni (E) and internet browser company Opera (OPRA), which fell 2.2% and 1.7% respectively. They were followed by biotech firm Evaxion (EVAX) and accommodations booking site trivago (TRVG), which were down 1% and 0.5% respectively.

The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and mining company BHP Group (BHP), which advanced 11% and 3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Bicycle Therapeutics (BCYC), which increased 1.6% and 0.4% respectively.

The decliners from the UK and Ireland were led by lender HSBC (HSBC) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which dropped 6.4% and 5.2% respectively. They were followed by educational publisher Pearson (PSO) and software firm Endava (DAVA), which lost 2.8% and 2.4% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment